Sharenet Sites 
Sharenet Sites
Further announcement regarding the disposal of rights to commercialise fondaparinux products in the US
ASPEN PHARMACARE HOLDINGS LIMITED
(“Aspen Holdings” or “the Company”)
(Incorporated in the Republic of South Africa)
Registration number: 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
and its subsidiaries (collectively “Aspen” or “the Group”)
FURTHER ANNOUNCEMENT REGARDING THE DISPOSAL OF RIGHTS TO COMMERCIALISE FONDAPARINUX
PRODUCTS IN THE US
Shareholders are referred to the announcement in respect of Aspen’s provisional financial results for the
year ended 30 June 2014, as released by Aspen Holdings on 10 September 2014 and wherein it was
confirmed, inter alia, that Aspen Global Incorporated (“AGI”) had entered into an agreement with Mylan
Ireland Limited (“Mylan”) in terms of which AGI will dispose of its rights to commercialise the fondaparinux
products it recently acquired from GSK (being Arixtra and the authorised generic thereof) in the United
States (“US”) to Mylan (“the Transaction”). In terms of this Transaction, AGI will enter into a supply
agreement to supply these fondaparinux products to Mylan on specified terms. The announcement further
confirmed that the Transaction would complete upon the satisfaction of certain conditions precedent,
including regulatory approvals.
Aspen is pleased to confirm that all conditions precedent have been met and that the Transaction was
completed on 25 September 2014.
Durban
26 September 2014
Sponsor:
Investec Bank Limited
Date: 26/09/2014 03:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
